{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:57:00Z","timestamp":1791385020471,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04097-2","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:42:57Z","timestamp":1752136977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of serum neuregulin 4 (NRG-4) levels on non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammad Amin","family":"Tapak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smko Rashidian","family":"Glolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"16","key":"4097_CR1","first-page":"715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict M, Zhang XJW. Non-alcoholic fatty liver disease. Expanded Rev. 2017;9(16):715.","journal-title":"Expanded Rev"},{"issue":"8","key":"4097_CR2","first-page":"1948","volume":"20","author":"S Marchisello","year":"2019","unstructured":"Marchisello S, Di Pino A, Scicali R, Urbano F, Piro S, Purrello F, et al. Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease. Overv. 2019;20(8):1948.","journal-title":"Overv"},{"key":"4097_CR3","doi-asserted-by":"publisher","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, Joukar F, Habibi A, Javid M, et al. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Arch Med Res. 2024;55(6):103043. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043. PMID: 39094335.","DOI":"10.1016\/j.arcmed.2024.103043"},{"key":"4097_CR4","doi-asserted-by":"publisher","unstructured":"Demir M, Lang S, Steffen HM. Nonalcoholic fatty liver disease - current status and future directions. J Dig Dis. 2015;16(10):541\u201357. https:\/\/doi.org\/10.1111\/1751-2980.12291. PMID: 26406351.","DOI":"10.1111\/1751-2980.12291"},{"key":"4097_CR5","doi-asserted-by":"publisher","unstructured":"Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci. 2017;18(8):1649. https:\/\/doi.org\/10.3390\/ijms18081649. PMID: 28758929; PMCID: PMC5578039.","DOI":"10.3390\/ijms18081649"},{"key":"4097_CR6","doi-asserted-by":"publisher","unstructured":"Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184\u2013223. https:\/\/doi.org\/10.3390\/ijms15046184. PMID: 24733068; PMCID: PMC4013623.","DOI":"10.3390\/ijms15046184"},{"key":"4097_CR7","doi-asserted-by":"publisher","unstructured":"Villarroya F, Cereijo R, Villarroya J, Giralt M. Brown adipose tissue as a secretory organ. Nat Rev Endocrinol. 2017;13(1):26\u201335. https:\/\/doi.org\/10.1038\/nrendo.2016.136. PMID: 27616452.","DOI":"10.1038\/nrendo.2016.136"},{"key":"4097_CR8","doi-asserted-by":"publisher","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397\u2013406. https:\/\/doi.org\/10.1074\/mcp.M113.035600. PMID: 24309898; PMCID: PMC3916642.","DOI":"10.1074\/mcp.M113.035600"},{"key":"4097_CR9","doi-asserted-by":"publisher","unstructured":"Pfeifer A. NRG4: an endocrine link between brown adipose tissue and liver. Cell Metab. 2015;21(1):13\u20134. https:\/\/doi.org\/10.1016\/j.cmet.2014.12.008. PMID: 25565202.","DOI":"10.1016\/j.cmet.2014.12.008"},{"key":"4097_CR10","doi-asserted-by":"publisher","unstructured":"Gum\u00e0 A, Mart\u00ednez-Redondo V, L\u00f3pez-Soldado I, Cant\u00f3 C, Zorzano A. Emerging role of neuregulin as a modulator of muscle metabolism. Am J Physiol Endocrinol Metab. 2010;298(4):E742\u201350. https:\/\/doi.org\/10.1152\/ajpendo.00541.2009. PMID: 20028964.","DOI":"10.1152\/ajpendo.00541.2009"},{"issue":"2","key":"4097_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.gendis.2023.03.021","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen M, Zhu J, Luo H, Mu W, Guo L. The journey towards physiology and pathology: tracing the path of neuregulin 4. Genes Dis. 2024;11(2):687\u2013700.","journal-title":"Genes Dis"},{"key":"4097_CR12","doi-asserted-by":"publisher","unstructured":"Christian M. Transcriptional fingerprinting of \"browning\" white fat identifies NRG4 as a novel adipokine. Adipocyte. 2014;4(1):50\u20134. https:\/\/doi.org\/10.4161\/adip.29853. PMID: 26167402; PMCID: PMC4496975.","DOI":"10.4161\/adip.29853"},{"key":"4097_CR13","doi-asserted-by":"publisher","unstructured":"Rosell M, Kaforou M, Frontini A, Okolo A, Chan YW, Nikolopoulou E, et al. Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice. Am J Physiol Endocrinol Metab. 2014;306(8):E945\u201364. https:\/\/doi.org\/10.1152\/ajpendo.00473.2013. PMID: 24549398; PMCID: PMC3989735.","DOI":"10.1152\/ajpendo.00473.2013"},{"key":"4097_CR14","doi-asserted-by":"publisher","unstructured":"Liu X, Hwang H, Cao L, Buckland M, Cunningham A, Chen J, et al. Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail. Proc Natl Acad Sci U S A. 1998;95(22):13024\u20139. https:\/\/doi.org\/10.1073\/pnas.95.22.13024. PMID: 9789034; PMCID: PMC23694.","DOI":"10.1073\/pnas.95.22.13024"},{"key":"4097_CR15","doi-asserted-by":"publisher","unstructured":"Yan P, Xu Y, Zhang Z, Gao C, Zhu J, Li H, et al. Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study. Cytokine. 2019;113:356\u201364. https:\/\/doi.org\/10.1016\/j.cyto.2018.10.007. Epub 2018 Oct 12. PMID: 30322810.","DOI":"10.1016\/j.cyto.2018.10.007"},{"key":"4097_CR16","doi-asserted-by":"publisher","unstructured":"Hu X, Fan Q, Hou H, Yan R. Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling. J Neurochem. 2016;136(2):234\u201349. https:\/\/doi.org\/10.1111\/jnc.13395. PMID: 26465092; PMCID: PMC4833723.","DOI":"10.1111\/jnc.13395"},{"key":"4097_CR17","doi-asserted-by":"publisher","unstructured":"D\u00edaz-S\u00e1ez F, Blanco-Sinfreu C, Archilla-Ortega A, Sebastian D, Romero M, Hern\u00e1ndez-Alvarez MI, et al. Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles. Int J Mol Sci. 2021;22(23):12960. https:\/\/doi.org\/10.3390\/ijms222312960. PMID: 34884763; PMCID: PMC8657571.","DOI":"10.3390\/ijms222312960"},{"key":"4097_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lfs.2018.12.006","volume":"217","author":"L Zhang","year":"2019","unstructured":"Zhang L, Bai M, Tang H, Zhou F, Zhu Q, Wang S, et al. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice. Life Sci. 2019;217:185\u201392.","journal-title":"Life Sci"},{"issue":"47","key":"4097_CR19","doi-asserted-by":"publisher","first-page":"39850","DOI":"10.1074\/jbc.M112.400846","volume":"287","author":"JK Bernard","year":"2012","unstructured":"Bernard JK, McCann SP, Bhardwaj V, Washington MK, Frey MR. Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo. J Biol Chem. 2012;287(47):39850\u20138.","journal-title":"J Biol Chem"},{"issue":"6","key":"4097_CR20","first-page":"1151","volume":"4","author":"M Ebi","year":"2011","unstructured":"Ebi M, Kataoka H, Shimura T, Hirata Y, Mizushima T, Mizoshita T, et al. The role of neuregulin4 and HER4 in Gastrointestinal malignant lymphoma. Mol Med Rep. 2011;4(6):1151\u20135.","journal-title":"Mol Med Rep"},{"issue":"6","key":"4097_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1530\/EC-19-0175","volume":"8","author":"M Li","year":"2019","unstructured":"Li M, Chen Y, Jiang J, Lu Y, Song Z, Zhang S, et al. Elevated serum neuregulin 4 levels in patients with hyperthyroidism. Endocr Connections. 2019;8(6):728\u201335.","journal-title":"Endocr Connections"},{"issue":"2","key":"4097_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/EJE-19-0017","volume":"181","author":"S Kralisch","year":"2019","unstructured":"Kralisch S, Hoffmann A, Kl\u00f6ting N, Frille A, Kuhn H, Nowicki M, et al. The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease. Eur J Endocrinol. 2019;181(2):151\u20139.","journal-title":"Eur J Endocrinol"},{"key":"4097_CR23","doi-asserted-by":"publisher","unstructured":"Chen M, Zhu J, Luo H, Mu W, Guo L. The journey towards physiology and pathology: Tracing the path of neuregulin 4. Genes Dis. 2023;11(2):687\u2013700. https:\/\/doi.org\/10.1016\/j.gendis.2023.03.021. PMID: 37692526; PMCID: PMC10491916.","DOI":"10.1016\/j.gendis.2023.03.021"},{"key":"4097_CR24","doi-asserted-by":"publisher","unstructured":"Dai YN, Zhu JZ, Fang ZY, Zhao DJ, Wan XY, Zhu HT, et al. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism. 2015;64(12):1667\u201373. https:\/\/doi.org\/10.1016\/j.metabol.2015.08.013. PMID: 26476959.","DOI":"10.1016\/j.metabol.2015.08.013"},{"key":"4097_CR25","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3(3):e123\u201330. PMID: 21603045; PMCID: PMC3090117."},{"key":"4097_CR26","unstructured":"Peters MD, Godfrey CM, McInerney P, Soares CB, Khalil H, Parker D. The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews. 2015."},{"key":"4097_CR27","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R et al. Chapter 7: Systematic reviews of etiology and risk. Joanna Bri ggs Institute Reviewer\u2019s Manual. The Joanna Briggs Institute. 2017. 2017;10:2019-05.","DOI":"10.46658\/JBIRM-17-06"},{"issue":"1","key":"4097_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"key":"4097_CR29","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142. https:\/\/doi.org\/10.1002\/14651858.ED000142. PMID: 31643080; PMCID: PMC10284251.","DOI":"10.1002\/14651858.ED000142"},{"key":"4097_CR30","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch VJ. Cochrane handbook for systematic reviews of interventions. Hoboken: Wiley; 2019; p. 4."},{"key":"4097_CR31","doi-asserted-by":"publisher","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557. PMID: 12958120; PMCID: PMC192859.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"4097_CR32","doi-asserted-by":"publisher","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186. PMID: 12111919.","DOI":"10.1002\/sim.1186"},{"key":"4097_CR33","doi-asserted-by":"publisher","unstructured":"Galv\u00e1n-Ram\u00edrez ML, Soto-Hern\u00e1ndez EE, Boj\u00f3rquez-P\u00e9rez R. Coinfection of Toxoplasma gondii and Other Microorganisms: A Systematic Review and Meta-Analysis. Microorganisms. 2024;12(10):2106. https:\/\/doi.org\/10.3390\/microorganisms12102106. PMID: 39458415; PMCID: PMC11510090.","DOI":"10.3390\/microorganisms12102106"},{"issue":"B","key":"4097_CR34","first-page":"1007","volume":"10","author":"TH Gado","year":"2022","unstructured":"Gado TH, Asal SA, Abdelraouf FH, AbdelSamie RJOAMJMS. Evaluating serum neuregulin 4 as a noninvasive biomarker in patients with Non-alcoholic. Fat Liver Disease. 2022;10(B):1007\u201313.","journal-title":"Fat Liver Disease"},{"key":"4097_CR35","doi-asserted-by":"publisher","unstructured":"De Munck TJI, Boesch M, Verhaegh P, Masclee AAM, Jonkers D, van Pelt JF, et al. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease? PLoS One. 2021;16(5):e0251822. https:\/\/doi.org\/10.1371\/journal.pone.0251822. PMID: 33989346; PMCID: PMC8121306.","DOI":"10.1371\/journal.pone.0251822"},{"key":"4097_CR36","doi-asserted-by":"publisher","unstructured":"Tutunchi H, Mobasseri M, Aghamohammadzadeh N, Hooshyar J, Naeini F, Najafipour F. Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): A case-control study. Int J Clin Pract. 2021;75(10):e14555. https:\/\/doi.org\/10.1111\/ijcp.14555. PMID: 34159710.","DOI":"10.1111\/ijcp.14555"},{"key":"4097_CR37","doi-asserted-by":"publisher","unstructured":"Wang R, Yang F, Qing L, Huang R, Liu Q, Li X. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity. Clin Obes. 2019;9(1):e12289. https:\/\/doi.org\/10.1111\/cob.12289. PMID: 30411515.","DOI":"10.1111\/cob.12289"},{"key":"4097_CR38","doi-asserted-by":"crossref","unstructured":"Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Funct Brown Adipose Tissue Healthy Adults. 2009;360(15):1518\u201325.","DOI":"10.1056\/NEJMoa0808949"},{"issue":"10","key":"4097_CR39","first-page":"1555","volume":"27","author":"MJO Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher MJO. Neuregulin 4: a hotline. Between Brown Fat Liver. 2019;27(10):1555\u20137.","journal-title":"Between Brown Fat Liver"},{"key":"4097_CR40","doi-asserted-by":"publisher","unstructured":"Chen Z, Wang GX, Ma SL, Jung DY, Ha H, Altamimi T, Zhao XY, et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Mol Metab. 2017;6(8):863\u201372. https:\/\/doi.org\/10.1016\/j.molmet.2017.03.016. PMID: 28752050; PMCID: PMC5518721.","DOI":"10.1016\/j.molmet.2017.03.016"},{"key":"4097_CR41","doi-asserted-by":"publisher","first-page":"26242","DOI":"10.1038\/srep26242","volume":"6","author":"Y Ma","year":"2016","unstructured":"Ma Y, Gao M, Liu D. Preventing high fat Diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer. Sci Rep. 2016;6:26242.","journal-title":"Sci Rep"},{"issue":"12","key":"4097_CR42","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.molmet.2016.09.009","volume":"5","author":"MT DiStefano","year":"2016","unstructured":"DiStefano MT, Roth Flach RJ, Senol-Cosar O, Danai LV, Virbasius JV, Nicoloro SM, et al. Adipocyte-specific Hypoxia-inducible gene 2 promotes fat deposition and diet-induced insulin resistance. Mol Metabolism. 2016;5(12):1149\u201361.","journal-title":"Mol Metabolism"},{"key":"4097_CR43","doi-asserted-by":"publisher","first-page":"1106380","DOI":"10.3389\/fphys.2022.1106380","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen M. Neuregulin 4 as a novel adipokine in energy metabolism. Front Physiol. 2022;13:1106380.","journal-title":"Front Physiol"},{"key":"4097_CR44","doi-asserted-by":"publisher","unstructured":"Tutov A, Chen X, Werner RA, M\u00fchlig S, Zimmermann T, Nose N, et al. Rationalizing the Binding Modes of PET Radiotracers Targeting the Norepinephrine Transporter. Pharmaceutics. 2023;15(2):690. https:\/\/doi.org\/10.3390\/pharmaceutics15020690. PMID: 36840011; PMCID: PMC9963373.","DOI":"10.3390\/pharmaceutics15020690"},{"issue":"12","key":"4097_CR45","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3713","volume":"20","author":"GX Wang","year":"2014","unstructured":"Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through Attenuation of hepatic lipogenesis. Nat Med. 2014;20(12):1436\u201343.","journal-title":"Nat Med"},{"key":"4097_CR46","doi-asserted-by":"publisher","unstructured":"Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med. 2014;20(12):1436\u201343. https:\/\/doi.org\/10.1038\/nm.3713. PMID: 25401691; PMCID: PMC4257907.","DOI":"10.1038\/nm.3713"},{"key":"4097_CR47","doi-asserted-by":"publisher","unstructured":"Chen LL, Peng MM, Zhang JY, Hu X, Min J, Huang QL, et al. Elevated circulating Neuregulin4 level in patients with diabetes. Diabetes Metab Res Rev. 2017;33(4). https:\/\/doi.org\/10.1002\/dmrr.2870. PMID: 27862843.","DOI":"10.1002\/dmrr.2870"},{"key":"4097_CR48","doi-asserted-by":"publisher","unstructured":"Jiang J, Lin M, Xu Y, Shao J, Li X, Zhang H, et al. Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults. Sci Rep. 2016;6:36710. https:\/\/doi.org\/10.1038\/srep36710. PMID: 27819316; PMCID: PMC5098181.","DOI":"10.1038\/srep36710"},{"key":"4097_CR49","doi-asserted-by":"publisher","unstructured":"Cai C, Lin M, Xu Y, Li X, Yang S, Zhang H. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study. BMC Med. 2016;14(1):165. https:\/\/doi.org\/10.1186\/s12916-016-0703-6. PMID: 27772531; PMCID: PMC5075753.","DOI":"10.1186\/s12916-016-0703-6"},{"key":"4097_CR50","doi-asserted-by":"publisher","unstructured":"Yan P, Xu Y, Wan Q, Feng J, Li H, Yang J, et al. Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus. Dis Markers. 2018;2018:6974191. https:\/\/doi.org\/10.1155\/2018\/6974191. PMID: 29721105; PMCID: PMC5867541.","DOI":"10.1155\/2018\/6974191"},{"key":"4097_CR51","doi-asserted-by":"publisher","unstructured":"Kralisch S, Hoffmann A, Kratzsch J, Bl\u00fcher M, Stumvoll M, Fasshauer M, et al. The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus. Diabetes Metab. 2018;44(2):150\u20134. https:\/\/doi.org\/10.1016\/j.diabet.2017.06.001. PMID: 28709749.","DOI":"10.1016\/j.diabet.2017.06.001"},{"key":"4097_CR52","doi-asserted-by":"publisher","unstructured":"Rahimzadeh M, Farshidi N, Naderi N, Farshidi H, Montazerghaem H. Clinical significance of serum concentrations of neuregulin-4, in acute coronary syndrome. Sci Rep. 2020;10(1):5797. https:\/\/doi.org\/10.1038\/s41598-020-62680-x. PMID: 32242042; PMCID: PMC7118153.","DOI":"10.1038\/s41598-020-62680-x"},{"key":"4097_CR53","doi-asserted-by":"publisher","unstructured":"Tian QP, Liu ML, Tang CS, Xue L, Pang YZ, Qi YF. Association of Circulating Neuregulin-4 with Presence and Severity of Coronary Artery Disease. Int Heart J. 2019;60(1):45\u20139. https:\/\/doi.org\/10.1536\/ihj.18-130. PMID: 30393265.","DOI":"10.1536\/ihj.18-130"},{"key":"4097_CR54","doi-asserted-by":"publisher","unstructured":"Kang YE, Kim JM, Choung S, Joung KH, Lee JH, Kim HJ,et al. Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes. Diabetes Res Clin Pract. 2016;117:1\u20133. https:\/\/doi.org\/10.1016\/j.diabres.2016.04.007. PMID: 27329015.","DOI":"10.1016\/j.diabres.2016.04.007"},{"key":"4097_CR55","doi-asserted-by":"publisher","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012. PMID: 26823198.","DOI":"10.1016\/j.metabol.2015.12.012"},{"issue":"7","key":"4097_CR56","first-page":"3347","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MaG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison euglycemic-hyperinsulinemic Clamp. 2010;95(7):3347\u201351.","journal-title":"Comparison euglycemic-hyperinsulinemic Clamp"},{"key":"4097_CR57","doi-asserted-by":"publisher","unstructured":"Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol Cell Endocrinol. 2015;418 Pt 1:55-65. https:\/\/doi.org\/10.1016\/j.mce.2015.02.018. PMID: 25724480.","DOI":"10.1016\/j.mce.2015.02.018"},{"key":"4097_CR58","doi-asserted-by":"publisher","unstructured":"Ma Y, Gao M, Liu D. Preventing High Fat Diet-induced Obesity and Improving Insulin Sensitivity through Neuregulin 4 Gene Transfer. Sci Rep. 2016;6:26242. https:\/\/doi.org\/10.1038\/srep26242. PMID: 27184920; PMCID: PMC4869101.","DOI":"10.1038\/srep26242"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04097-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:49:14Z","timestamp":1757209754000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4097"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04097-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study, as it is a meta-analysis and did not involve the collection of primary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"509"}}